Provincial Public Health Office, Phetchabun Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2002
NCT01107275
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rabies (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1